114 related articles for article (PubMed ID: 10945607)
1. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer.
Jang JH; Shin KH; Park YJ; Lee RJ; McKeehan WL; Park JG
Cancer Res; 2000 Aug; 60(15):4049-52. PubMed ID: 10945607
[TBL] [Abstract][Full Text] [Related]
2. Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.
Soverini S; Terragna C; Testoni N; Ruggeri D; Tosi P; Zamagni E; Cellini C; Cavo M; Baccarani M; Tura S; Martinelli G
Haematologica; 2002 Oct; 87(10):1036-40. PubMed ID: 12368157
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells.
Jang JH
Biochem Biophys Res Commun; 2002 Mar; 292(2):378-82. PubMed ID: 11906172
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.
Murgue B; Tsunekawa S; Rosenberg I; deBeaumont M; Podolsky DK
Cancer Res; 1994 Oct; 54(19):5206-11. PubMed ID: 7923141
[TBL] [Abstract][Full Text] [Related]
6. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
[TBL] [Abstract][Full Text] [Related]
7. Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells.
Mosselman S; Claesson-Welsh L; Kamphuis JS; van Zoelen EJ
Cancer Res; 1994 Jan; 54(1):220-5. PubMed ID: 8261442
[TBL] [Abstract][Full Text] [Related]
8. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
Bruno IG; Jin W; Cote GJ
Hum Mol Genet; 2004 Oct; 13(20):2409-20. PubMed ID: 15333583
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis.
Jang JH
Oncogene; 2005 Jan; 24(5):945-8. PubMed ID: 15558020
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.
Tomlinson DC; L'Hôte CG; Kennedy W; Pitt E; Knowles MA
Cancer Res; 2005 Nov; 65(22):10441-9. PubMed ID: 16288035
[TBL] [Abstract][Full Text] [Related]
11. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers.
Jang JH; Shin KH; Park JG
Cancer Res; 2001 May; 61(9):3541-3. PubMed ID: 11325814
[TBL] [Abstract][Full Text] [Related]
12. An activated 5' cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id).
Denecke J; Kranz C; Kemming D; Koch HG; Marquardt T
Hum Mutat; 2004 May; 23(5):477-86. PubMed ID: 15108280
[TBL] [Abstract][Full Text] [Related]
13. A premature termination codon within an alternative exon affecting only the metabolism of transcripts that retain this exon.
Maillet P; Dalla Venezia N; Lorenzo F; Morinière M; Bozon M; Noël B; Delaunay J; Baklouti F
Hum Mutat; 1999; 14(2):145-55. PubMed ID: 10425037
[TBL] [Abstract][Full Text] [Related]
14. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
Duval A; Rolland S; Tubacher E; Bui H; Thomas G; Hamelin R
Cancer Res; 2000 Jul; 60(14):3872-9. PubMed ID: 10919662
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse.
Wuechner C; Nordqvist AC; Winterpacht A; Zabel B; Schalling M
Int J Dev Biol; 1996 Dec; 40(6):1185-8. PubMed ID: 9032024
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.
Takaishi S; Sawada M; Morita Y; Seno H; Fukuzawa H; Chiba T
Biochem Biophys Res Commun; 2000 Jan; 267(2):658-62. PubMed ID: 10631118
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.
Wu R; Connolly D; Ngelangel C; Bosch FX; Muñoz N; Cho KR
Oncogene; 2000 Nov; 19(48):5543-6. PubMed ID: 11114733
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs.
Terada M; Shimizu A; Sato N; Miyakaze SI; Katayama H; Kurokawa-Seo M
Mol Cell Biol Res Commun; 2001 Nov; 4(6):365-73. PubMed ID: 11703096
[TBL] [Abstract][Full Text] [Related]
20. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
